Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

Q. My doctor prescribed raloxifene when I was in my 50s because my mother had died of breast cancer. She believed this drug ...

The trial focused on a drug called Duavee, a combination of conjugated estrogens and bazedoxifene, which is already approved ...

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Earlier this month, the U.S. Food and Drug Administration (FDA) issued a warning regarding two popular allergy medications.